Bedoya-Toro Munera Maria E's Form 4 filing
Dermata Therapeutics, Inc. (DRMA) · filed Mar 17, 2026
- Accession no.
- 0001493152-26-010630
- Filed
- Mar 17, 2026
- Trade date
- Feb 17, 2026
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.27K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bedoya-Toro Munera Maria ECIK 0001400048 | Officer (SVP, Regulatory Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | PPurchaseAcquired | +1,000 | $1.27 | +$1,270 | 1,012 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.